Business · 27/05/20091 min read

FDA Releases Draft Guidance on Presenting Risk Information in Prescription Drug and Medical Device Promotion

The Food and Drug Administration (FDA) has released a draft guidance for the pharmaceutical and medical device industries on presenting risk information in promotional materials, responding to stakeholder requests for clearer guidelines.